Jaguar LAA, Inc. Acquires Assets for Laminar Program
Jaguar LAA, Inc. announced the acquisition of assets related to its Laminar program. The company intends to advance the program, which focuses on left atrial appendage closure for patients with non-valvular atrial fibrillation.
SANTA ROSA, Calif. – Medical device company Jaguar LAA, Inc. has announced it is acquiring assets associated with its Laminar program. The acquisition is intended to allow the company to further develop the program, which targets a differentiated approach to left atrial appendage closure for patients diagnosed with non-valvular atrial fibrillation.
Non-valvular atrial fibrillation is a common heart rhythm disorder that can increase the risk of stroke. Left atrial appendage closure is one method used to mitigate this risk.
Jaguar LAA, Inc. is a privately held company focused on developing medical devices for cardiovascular conditions.
Further details regarding the company's strategic plans for the program or the terms of the acquisition were not immediately disclosed.